SCHEMBL13639461

SCHEMBL13639461

Nc1ccc(-c2cccc(S(=O)(=O)Nc3ccccc3S(N)(=O)=O)c2)cc1Cl

nearest known ligand 0.82

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTGES2 Q9H7Z7 20/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3773690 0.90 PTGES2 (1.00) PTGES2
SCHEMBL13639414 0.85 PTGES2 (0.85) PTGES2
SCHEMBL3788588 0.85 PTGES2 (1.00) PTGES2
SCHEMBL13639443 0.84 PTGES2 (0.82) PTGES2
SCHEMBL3776677 0.81 PTGES2 (1.00) PTGES2
SCHEMBL3776754 0.81 PTGES2 (1.00) PTGES2
SCHEMBL3786330 0.80 PTGES2 (1.00) PTGES2
SCHEMBL3782540 0.80 PTGES2 (1.00) PTGES2
SCHEMBL3777779 0.80 PTGES2 (1.00) PTGES2
SCHEMBL3775690 0.79 PTGES2 (1.00) PTGES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2234993-B1 BIS- (SULF ONYLAMINO) DERIVATIVES FOR USE IN THERAPY ASTRAZENECA AB (SE) 2012-11-07 EP disclosed